JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 9, 2005; DOI: 10.1124/jpet.105.085274


0022-3565/05/3143-1042-1051$20.00
JPET 314:1042-1051, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.085274v1
314/3/1042    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soto, D.
Right arrow Articles by Gasull, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soto, D.
Right arrow Articles by Gasull, X.

CELLULAR AND MOLECULAR

Effects of Dinucleoside Polyphosphates on Trabecular Meshwork Cells and Aqueous Humor Outflow Facility

David Soto, Jesús Pintor, Assumpta Peral, Arcadi Gual, and Xavier Gasull

Laboratori de Neurofisiologia, Facultat de Medicina-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain (D.S., A.G., X.G.); and Departamentos de Bioquímica (J.P.) and Óptica (A.P.), Escuela Universitaria de Óptica, Universidad Complutense de Madrid, Spain

The most important risk factor for the development of glaucoma is elevated intraocular pressure (IOP). Hypotensive drugs decrease IOP, preventing optic nerve damage and further vision loss. The balance between aqueous humor (AH) production and drainage determines IOP, and problems in AH outflow pathways are associated with open-angle glaucoma development. Previous studies have shown the presence of diadenosine tetraphosphate (Ap4A) and pentaphosphate (Ap5A) in the AH. Topic application of Ap4A to the cornea decreased IOP, whereas Ap5A increased it. Because dinucleoside polyphosphates stimulate P2Y purinergic receptors, we studied their presence in trabecular meshwork (TM) cells. Additionally, the effects of diadenosine polyphosphates (ApnAs; n = 3–5) and Up4U (P1,P4-(diuridine 5')-tetraphosphate; INS365) in outflow facility were tested. P2Y1, P2Y2, and P2Y4 receptors were detected in TM cells by Western blot and immunocytochemistry. In TM cells, Ap3A, Ap4A, and Ap5A induced discrete intracellular calcium concentration ([Ca2+]i) mobilizations compared with higher and more sustained [Ca2+]i mobilizations after Up4U application. In bovine ocular anterior segments perfused at constant pressure, 1 µM Ap3A or Ap4A increased outflow facility, whereas Up4U or Ap5A did not modify it. 2-MeSADP, a selective P2Y1 agonist, induced outflow facility increases similar to those obtained after Ap3A and Ap4A, and these were prevented by addition of the selective P2Y1 receptor antagonist MRS-2179 (2'-deoxy-N6-methyladenosine-3',5'-diphosphate). Our results demonstrate that the hypotensive effect of Ap4A and other dinucleotides is mediated, at least in part, by increasing trabecular outflow facility through activation of P2Y1 receptors. The latter would seem to be an interesting target in the development of antiglaucomatous drugs to selectively increase AH outflow.


Received February 22, 2005; accepted June 7, 2005.

Address correspondence to: Dr. Xavier Gasull, Laboratori de Neurofisiologia, Facultat de Medicina-U.B., Casanova 143, E-08036 Barcelona, Spain. E-mail: xgasull{at}ub.edu




This article has been cited by other articles:


Home page
IOVSHome page
C. Mayo, R. Ren, C. Rich, M. A. Stepp, and V. Trinkaus-Randall
Regulation by P2X7: Epithelial Migration and Stromal Organization in the Cornea
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4384 - 4391.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. Abad, G. Lorente, N. Gavara, M. Morales, A. Gual, and X. Gasull
Activation of Store-Operated Ca2+ Channels in Trabecular Meshwork Cells
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 677 - 686.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
V. E. Tovell and J. Sanderson
Distinct P2Y Receptor Subtypes Regulate Calcium Signaling in Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 350 - 357.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Burnstock
Physiology and Pathophysiology of Purinergic Neurotransmission
Physiol Rev, April 1, 2007; 87(2): 659 - 797.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Mediero, A. Peral, and J. Pintor
Dual roles of diadenosine polyphosphates in corneal epithelial cell migration.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4500 - 4506.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
G. Burnstock
Pathophysiology and therapeutic potential of purinergic signaling.
Pharmacol. Rev., March 1, 2006; 58(1): 58 - 86.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.